Fundraising FoxBrightangeltherapeutics
Toronto, CA · 2 known investors
Find your way into Brightangeltherapeutics
Sign up to see every warm intro you have to Brightangeltherapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Brightangeltherapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Bright Angel Therapeutics is a pre-clinical stage biotechnology company developing small-molecule antifungal therapeutics aimed at drug-resistant and life-threatening invasive fungal infections. It designs fungal-selective inhibitors targeting fungal stress responses, using Schrödinger's computational drug discovery platform alongside its own proprietary technologies.
Founders & leadership
Investors · 2
Frequently asked questions
- What does Brightangeltherapeutics do?
- Bright Angel Therapeutics is a pre-clinical stage biotechnology company developing small-molecule antifungal therapeutics aimed at drug-resistant and life-threatening invasive fungal infections. It designs fungal-selective inhibitors targeting fungal stress responses, using Schrödinger's computational drug discovery platform alongside its own proprietary technologies.
- Who founded Brightangeltherapeutics?
- Brightangeltherapeutics was founded by Leah Cowen, Luke Whitesell.
- Who are Brightangeltherapeutics's investors?
- Brightangeltherapeutics's investors include Lumira Ventures, Toronto Innovation Acceleration Partners.
- Where is Brightangeltherapeutics headquartered?
- Brightangeltherapeutics is headquartered in Toronto, CA.